Drugmakers shelled out $25K to get into painkiller-approval summit

Pain-drug developers paid $25,000 to attend a closed summit meeting on clinical trials sufficient to win FDA approval, The Washington Post reports. The academics who ran the meeting, which was designed to gather information for developing agency guidelines for drug development, took a hard-sell approach, the Post reports, and drugmakers were eager to pay the freight for a chance to participate. Report